Rising Tide Portfolio Company, Aspect Biosystems, Strikes $2.7 Billion Strategic Partnership with Novo Nordisk to Treat Diabetes and Obesity
By Brent MacDonald
Upfront payment of $75 Million, up to $2.6 Billion in milestone payments from collaboration, plus tiered royalties. By Brent MacDonald – Partner at Rising Tide Aspect Biosystems (herewith “Aspect”) seeks to revolutionize drug development, personalized medicine, and regenerative medicine by becoming the global leader in 3D human tissue technology. Its disruptive 3D bioprinting platform technology […]